Search

EHA-AAH Joint membership

We are pleased to inform that EHA and the Albanian Association of Hematology (AAH) have joined forces and are offering you the possibility of an EHA-AAH Joint Membership in 2023.

Read more

Improved survival for adult Acute Lymphoblastic Leukemia (ALL) patients

Historical survival for patients 18-45 years with ALL is approximately 40 %. However the event free survival for ALL patients 18-45 years has improved to 73% following implementation of the NOPHO ALL2008 protocol in July 2008.

Read more

EHA-TSH Hematology Tutorial

EHA is joining the Turkish Society of Hematology (TSH) to organize the EHA-TSH Hematology Tutorial on T Cell Lymphomas. Date: June 29-30, 2024
Location: Ankara, Türkiye
Format: In-Person

Target audienceHematology fellows from Türkiye.

Read more

EHA-SfPM Precision Medicine Meeting

EHA and SfPM (Society for Functional Precision Medicine) are proud to present the first joint meeting on Precision Medicine.

Read more

EHA-AHA Joint membership

We are pleased to inform that EHA and the Armenian Hematology Association (AHA) have joined forces and are offering you the possibility of an EHA-AHA Joint Membership in 2023.

Read more

EHA-SFH Joint membership

We are pleased to inform that EHA and the Société Française d’Hématologie (SFH) have joined forces and are offering you the possibility of an EHA-SFH Joint Membership in 2024.

Read more

EHA-SRH Joint membership

We are pleased to inform that EHA and the Societatea Română de Hematologie (SRH) have joined forces and are offering you the possibility of an EHA-SRH Joint Membership in 2023.

Read more

Support opportunities

EHA Ranking for 2024 is now accessible via this link. EHA thrives on the support of the biomedical industry and the medical profession. The variety of opportunities available for industry range from educational activities to the EHA Congress.

Read more

Faculty Information

We are honored that you have agreed to be part of the faculty for the EHA-ISHBT Hematology Tutorial, to be held on March 1-3, 2024 in Hyderabad, India.

Read more